NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
Treatment & Care
  • Introduction to HIV and AIDS
    • The immune system and HIV
      • Medical monitoring
        • Accessing medical care
          • Ways of attacking HIV
            • Preventing HIV infection
              • Starting HIV treatment
                • When to start treatment
                • Choosing a combination
              • Side-effects
                • Adherence
                  • Drug resistance
                    • Drug interactions and pharmacokinetics
                      • Changing HIV treatment
                        • Interrupting HIV treatment
                          • HIV treatment during pregnancy
                            • HIV treatment in children
                              • Genetics and HIV treatment
                                • Treatment guidelines
                                  • Preventing infections
                                    • Antiretroviral therapy in resource-limited settings
                                      • Drugs used by people with HIV
                                        • Symptoms and illnesses
                                          • Alternative & complementary therapies
                                            support our work today
                                            YOU ARE HERE
                                            • > Home
                                              • > Treatment & Care
                                                • > Treatment & Care

                                            Starting HIV treatment

                                            printer-friendly versionsend to a friendglossarycomment

                                            • When to start treatment
                                            • Choosing a combination

                                            latest aidsmap news

                                            • High rate of death amongst patients with HIV diagnosed late
                                            • CD4 cell count increases sustained up to five years in developing-world treatment programmes
                                            • Raltegravir may have role in PEP if exposure involves drug-resistant HIV
                                            • Excellent outcomes from five years of antiretroviral use in Botswana
                                            • Study explores verbal and non-verbal communication in unprotected sex between men
                                            • IL-2 provides quick ‘AIDS rescue’, but effect does not always last
                                            • Once-a-day etravirine should work as first-line treatment
                                            • Second-line combinations fail twice as often as first-line ones in the first year
                                            • If you can't switch, better to stay on failing treatment than stop it, studies show
                                            • Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’
                                             
                                            • Contact NAM
                                            • Get Email Updates
                                            • Disclaimer
                                            • Copyright
                                            • Developed By NAM